skip to Main Content

Advocacy Letters and Policy Documents

Advocacy is a core component of the GTMRx Institute’s mission and vision, and our policy positions are aimed at helping to advance acceptance and recognition of the importance of creating a systematic, evidence-based approach to medications and their rational use—comprehensive medication management (CMM). To ensure the stability and success of CMM services, we regularly advocate to the Centers for Medicare and Medicaid (CMS), members of Congress, open forums/requests for information and policymakers.

GTMRx’s advocacy efforts and letters along with policy recommendation documents include:

2022-08-31

Recommendation Letter to the Centers for Medicare and Medicaid Services on the Medicare Advantage program (Document Citation 87 46918)

Read

2022-07-26

Recommendation Letter to the Office of the Assistant Secretary of Health (OASH) on the HHS Initiative to Strengthen Primary Health Care (Document Citation 87 FR 38168)

Read

2022-05-27

Recommendation Letter to the Health Care Payment Learning & Action Network (HCPLAN) on their definition of “accountable care” and the Accountable Care Commitment Curve

Read

2022-05-23

Discussion Document on Optimizing Medication Use Through Comprehensive Medication Management (CMM) in Practice: Strategic Recommendations for Implementing CMM into the Care Team with Sustainable Payment and Practice Structures

Read

2022-02-28

Sign On Letter of Support to the Personalized Medicine Caucus Co-Chairs—Representatives Tom Emmer (R-MN) and Eric Swalwell (D-CA)—on the Right Drug Dose Now Act 

Read

2022-01-26

Recommendation Letter to the Personalized Medicine Caucus Co-Chairs—Representatives Tom Emmer (R-MN) and Eric Swalwell (D-CA)—on the Right Drug Dose Now Act 

Read

2021-09-13

Letter to CMS about Payment Mechanisms for Medication Management Services through the proposed Medicare Physician Fee Schedule (CMS-1751-P)

Read

2021-06-21

PGx Payment Policy Recommendations from the GTMRx Institute

Read

2021-03-01

Letter to the Office of Personnel Management (OPM)’s request for information about OPM Pharmacy Benefits – Notice ID 24322621R0004

Read

2020-12-14

Letter to President Biden’s transition team about the need for team-based comprehensive medication management to improve patient-centered care
Read

2020-07-29

Letter to CMS about the interim final rule (effective May 8th, 2020) regarding coverage of medication management services under Medicare Part B (the “IFC”)

Read
Back To Top
×Close search
Search

We need your help now more than ever!